Literature DB >> 30191181

Metabolic Activity of Sulfate-Reducing Bacteria from Rodents with Colitis.

Jozef Kováč1, Monika Vítězová1, Ivan Kushkevych1.   

Abstract

Sulfate-reducing bacteria (SRB) are anaerobic microorganisms, which use sulfate as an electron acceptor in the process of dissimilatory sulfate reduction. The final metabolic product of these anaerobic microorganisms is hydrogen sulfide, which is known as toxic and can lead to damage to epithelial cells of the large intestine at high concentrations. Different genera of SRB are detected in the large intestine of healthy human and animals, and with diseases like Crohn's disease and ulcerative colitis. SRB isolated from rodents with ulcerative colitis have produced 1.14 (mice) and 1.03 (rats) times more sulfide ions than healthy rodents. The species of Desulfovibrio genus are the most widespread among all SRB in the intestine. The object of our research was to observe and compare the difference of production of sulfide and reduction of sulfate in intestinal SRB isolated from healthy rodents and rodents with ulcerative colitis.

Entities:  

Keywords:  Desulfovibrio genera; Hydrogen sulfide; Sulfate-reducing bacteria; Ulcerative colitis

Year:  2018        PMID: 30191181      PMCID: PMC6124154          DOI: 10.1515/med-2018-0052

Source DB:  PubMed          Journal:  Open Med (Wars)


  19 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa.

Authors: 
Journal:  FEMS Microbiol Ecol       Date:  2000-12-01       Impact factor: 4.194

Review 3.  Sulphate reducing bacteria and hydrogen metabolism in the human large intestine.

Authors:  G R Gibson; G T Macfarlane; J H Cummings
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

4.  Sulfate-reducing anaerobic bacteria in human feces.

Authors:  H Beerens; C Romond
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

5.  Carbon monoxide cycling by Desulfovibrio vulgaris Hildenborough.

Authors:  Gerrit Voordouw
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

Review 6.  Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy.

Authors:  Anja Schirbel; Claudio Fiocchi
Journal:  J Dig Dis       Date:  2010-10       Impact factor: 2.325

7.  Chemiluminescent detection of enzymatically produced hydrogen sulfide: substrate hydrogen bonding influences selectivity for H2S over biological thiols.

Authors:  T Spencer Bailey; Michael D Pluth
Journal:  J Am Chem Soc       Date:  2013-11-06       Impact factor: 15.419

8.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.

Authors:  Julien Loubinoux; Jean-Pierre Bronowicki; Ines A C Pereira; Jean-Louis Mougenel; Alain E Faou
Journal:  FEMS Microbiol Ecol       Date:  2002-05-01       Impact factor: 4.194

Review 9.  Intestinal bacteria and ulcerative colitis.

Authors:  J H Cummings; G T Macfarlane; S Macfarlane
Journal:  Curr Issues Intest Microbiol       Date:  2003-03

10.  The diversity of sulfate-reducing bacteria in the seven bioreactors.

Authors:  Ivan Kushkevych; Jozef Kováč; Monika Vítězová; Tomáš Vítěz; Milan Bartoš
Journal:  Arch Microbiol       Date:  2018-04-02       Impact factor: 2.552

View more
  12 in total

1.  ATP sulfurylase activity of sulfate-reducing bacteria from various ecotopes.

Authors:  Daryna Abdulina; Jozef Kováč; Galyna Iutynska; Ivan Kushkevych
Journal:  3 Biotech       Date:  2020-01-22       Impact factor: 2.406

2.  Adenosine-5'-Phosphosulfate- and Sulfite Reductases Activities of Sulfate-Reducing Bacteria from Various Environments.

Authors:  Ivan Kushkevych; Daryna Abdulina; Jozef Kováč; Dani Dordević; Monika Vítězová; Galyna Iutynska; Simon K-M R Rittmann
Journal:  Biomolecules       Date:  2020-06-17

3.  Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways.

Authors:  Shiri Li; Chie Takasu; Hien Lau; Lourdes Robles; Kelly Vo; Ted Farzaneh; Nosratola D Vaziri; Michael J Stamos; Hirohito Ichii
Journal:  Antioxidants (Basel)       Date:  2020-04-24

Review 4.  Sulfate-Reducing Bacteria of the Oral Cavity and Their Relation with Periodontitis-Recent Advances.

Authors:  Ivan Kushkevych; Martina Coufalová; Monika Vítězová; Simon K-M R Rittmann
Journal:  J Clin Med       Date:  2020-07-23       Impact factor: 4.241

5.  The Sulfate-Reducing Microbial Communities and Meta-Analysis of Their Occurrence during Diseases of Small-Large Intestine Axis.

Authors:  Ivan Kushkevych; Oľga Leščanová; Dani Dordević; Simona Jančíková; Jan Hošek; Monika Vítězová; Leona Buňková; Lorenzo Drago
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 6.  Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development.

Authors:  Ivan Kushkevych; Dani Dordević; Monika Vítězová
Journal:  J Adv Res       Date:  2020-03-24       Impact factor: 10.479

7.  Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.

Authors:  Ying Hong; Lili Sheng; Jing Zhong; Xin Tao; Weize Zhu; Junli Ma; Juan Yan; Aihua Zhao; Xiaojiao Zheng; Gaosong Wu; Bingbing Li; Bangxing Han; Kan Ding; Ningning Zheng; Wei Jia; Houkai Li
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  The Characterization of Enterococcus Genus: Resistance Mechanisms and Inflammatory Bowel Disease.

Authors:  Michaela Růžičková; Monika Vítězová; Ivan Kushkevych
Journal:  Open Med (Wars)       Date:  2020-04-03

Review 9.  Recent Advances in Metabolic Pathways of Sulfate Reduction in Intestinal Bacteria.

Authors:  Ivan Kushkevych; Jiří Cejnar; Jakub Treml; Dani Dordević; Peter Kollar; Monika Vítězová
Journal:  Cells       Date:  2020-03-12       Impact factor: 6.600

10.  Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases.

Authors:  Ivan Kushkevych; Věra Kotrsová; Dani Dordević; Leona Buňková; Monika Vítězová; Amedeo Amedei
Journal:  Biomolecules       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.